Fintel reports that on November 8, 2024, Stifel upgraded their outlook for Orthofix Medical (NasdaqGS:OFIX) from Hold to Buy. As of October 22, 2024, the average one-year price target for Orthofix ...
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global ...
Orthofix Medical Inc.'s merger with SeaSpine has not significantly impacted investor sentiment or market expectations. Despite reasonable Q1 financial results, the lack of forecasted revenue growth ...
TAIPEI, Nov. 4, 2024 /PRNewswire/ -- On November 1, 2024, ARTERY Technology, in partnership with its Korean distributor IGM, successfully hosted the "2024 AT32 MCU Application Training" in Seoul. The ...
Find the latest Orthofix Medical Inc. (OFIX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Barrington Lifts PT on Orthofix Medical (OFIX) to $17 From $16, Keeps an Overweight Rating Orthofix Medical Inc. (NASDAQ:OFIX) is one of the best medical device stocks to buy according to analysts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results